Home / Etravirine / United States
US ATC J05AG04 · updated 2 Nov 2026
Etravirine shortage in United States
Is there an Etravirine shortage in United States?
Yes. As of 2 Nov 2026, 2 Etravirine products are reported short in United States, the first since 28 Apr 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Etravirine, Tablet, 100 mg (NDC 10147-0570-1) discontinuation | Janssen Research and Development | 28 Apr 2026 | not given | Not stated |
| US | Intelence, Tablet, 100 mg (NDC 59676-570-01) discontinuation | Janssen Research and Development | 28 Apr 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).